COVID-19 infection in Crohn's disease under treatment with adalimumab

被引：41
|
作者：
Tursi, Antonio [1 ]
Angarano, Gioacchino [2 ]
Monno, Laura [2 ]
Saracino, Annalisa [2 ]
Signorile, Fabio [2 ]
Ricciardi, Aurelia [2 ]
Papa, Alfredo [3 ]
机构：
[1] Azienda Sanit Locale Barletta Andria Trani, Gastroenterol Serv, Andria, Puglia, Italy
[2] Univ Bari, Bari Univ Hosp, Div Infect Dis, Bari, Puglia, Italy
[3] Univ Cattolica Sacro Cuore, Fac Med & Surg, Div Internal Med & Gastroenterol, Complesso Integrato Columbus, Rome, Lazio, Italy
来源：
GUT | 2020年 / 69卷 / 07期
关键词：
crohn's disease; immune response;
D O I：
10.1136/gutjnl-2020-321240
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1364 / +
页数：2
相关论文
共 50 条
  • [1] Covid-19 Infection in a Patient with Crohn's Disease Under Treatment with Ustekinumab-Case Report
    Michael, Chiorean
    Puza, Sharma
    Benjamin, Chastek
    Leonardo, Salese
    Elizabeth, Bell
    Jesse, Peterson-Brandt
    Joseph, Cappelleri
    Xiang, Guo
    Nabeel, Khan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S5 - S6
  • [2] A Crohn's Disease Flare Masquerading as COVID-19 Infection
    Groudan, Kevin
    Greeff, Yesenia
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S1032 - S1032
  • [3] Tuberculosis mimicking Crohn's disease and respiratory infection by COVID-19
    Estebanez Ferrero, Beatriz
    Ruiz Pardo, Jose
    Velasco Albendea, Francisco Javier
    Vidana Marquez, Elisabet
    Moreno Moraleda, Isabel
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2022, 45 : 13 - 15
  • [4] Acute kidney injury caused by COVID-19 in a patient with Crohn's disease treated with adalimumab
    Lenti, Marco Vincenzo
    Gregorini, Marilena
    Borrelli de Andreis, Federica
    Rampino, Teresa
    D'Ambrosio, Gioacchino
    Verga, Laura
    Vanoli, Alessandro
    Mengoli, Caterina
    Ravetta, Valentina
    Paulli, Marco
    Di Sabatino, Antonio
    JOURNAL OF CLINICAL PATHOLOGY, 2021, 74 (08) : 540 - 542
  • [5] Adalimumab for the treatment of Crohn's disease
    Cassinotti, Andrea
    Ardizzone, Sandro
    Porro, Gabriele Bianchi
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (04): : 763 - 777
  • [6] Adalimumab for the treatment of Crohn's disease
    Devlin, Shane M.
    Panaccione, Remo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (07) : 1011 - 1019
  • [7] QUALITY OF LIFE IN PATIENTS WITH CROHN'S DISEASE UNDER TREATMENT WITH ADALIMUMAB
    Sanjurjo Lucia, Fuster
    Laya Beatriz, Salazar
    Penin Isaura, Rodriguez
    Sandomingo Laura, Lopez
    Urbistondo Gema, Dominguez
    Barreira Rebeca, Iglesias
    ATENCION FARMACEUTICA, 2010, 12 (06): : 375 - 378
  • [8] Adalimumab for the treatment of pediatric Crohn's disease
    Nuti, Federica
    Fiorino, Gionata
    Danese, Silvio
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (09) : 963 - 972
  • [9] COVID-19 infection in a patientwith Cushing's disease on osilodrostat treatment
    Boguslawska, Anna
    Minasyan, Mari
    Hubalewska-Dydejczyk, Alicja
    Gilis-Januszewska, Aleksandra
    ENDOKRYNOLOGIA POLSKA, 2023, 74 (03) : 342 - 343
  • [10] New Diagnosis of Crohn's Disease After COVID-19
    Lin, Zilan
    Rosman, Michael
    Lebovics, Edward
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S1482 - S1482
12345